Cardiol Therapeutics

CRDLNASDAQ
$1.91
-0.07-3.54%
Pre-Market: Jul 3, 4:22 PM EDT
15 minutes delayed

Cardiol Therapeutics (NASDAQ:CRDL) Stock, Earnings Estimates, EPS, And Revenue

Cardiol Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Aug 8
EPS Estimate
$-0.090
Quarterly Revenue Estimate
Annual Revenue
(as of Mar 31)

Analyze the earnings history of Cardiol Therapeutics using advanced sorting and filters.

Get Alert
CRDL
Cardiol Therapeutics
-$0.09-$0.09$0.0008/08/2024Get Alert
CRDL
Cardiol Therapeutics
-$0.08-$0.10-$0.100.00%$0.00$0.0005/14/2024Get Alert
CRDL
Cardiol Therapeutics
-$0.08-$0.12-$0.0925.00%$0.00$0.0004/01/2024Get Alert
CRDL
Cardiol Therapeutics
-$0.10-$0.09-$0.0722.22%$0.00$0.0011/14/2023Get Alert
CRDL
Cardiol Therapeutics
-$0.08-$0.09$0.00$0.0008/10/2023Get Alert
CRDL
Cardiol Therapeutics
-$0.11-$0.08$0.00$0.0005/15/2023Get Alert
CRDL
Cardiol Therapeutics
-$0.11-$0.11-$0.0827.27%$0.00$0.0003/29/2023Get Alert
CRDL
Cardiol Therapeutics
-$0.23-$0.10$0.00$0.0011/10/2022Get Alert
CRDL
Cardiol Therapeutics
-$0.13-$0.08$64.10K$0.0008/10/2022Get Alert
CRDL
Cardiol Therapeutics
-$0.21-$0.11$0.00$0.0005/16/2022Get Alert
CRDL
Cardiol Therapeutics
-$0.11$0.0003/23/2022Get Alert
CRDL
Cardiol Therapeutics
-$0.10-$0.18$0.00$0.0011/15/2021Get Alert

Cardiol Therapeutics (CRDL) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Mar 20242024-05-14$-0.10$-0.100.00 %
Mar 20242024-04-01$-0.09$-0.1225.0 %
Sep 20232023-11-14$-0.07$-0.0922.2 %
Dec 20222023-03-29$-0.08$-0.1127.3 %

Cardiol Therapeutics (CRDL) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Cardiol Therapeutics (NASDAQ:CRDL) reporting earnings?

A

Cardiol Therapeutics (CRDL) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 14, 2024 for Q1.

Q

What were the latest earnings per share (EPS) for Cardiol Therapeutics (NASDAQ:CRDL)?

A

The Actual EPS was $-0.10, which hit the estimate of $-0.10.

Q

What were Cardiol Therapeutics’s (NASDAQ:CRDL) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.